Q

Qinjing Zeng

Star Technology and Research (United States)

Publishes on Acute Kidney Injury Research, Trauma, Hemostasis, Coagulopathy, Resuscitation, Sepsis Diagnosis and Treatment. 10 papers and 122 citations.

10Publications
122Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

MiR-501-5p alleviates cardiac dysfunction in septic patients through targeting NR4A3 to prevent its binding with Bcl-2
Lan Gao, Zhongjie Zhai, Qindong Shi et al.|Cell Cycle|2022
Cited by 9Open Access

Sepsis-induced myocardial dysfunction is a common complication in septic patients. To date, a limited number of biomarkers that could predict cardiomyocyte apoptosis have been explored. In this study, we successfully established a cecal ligation and puncture (CLP)-induced septic model, and it was found that miR-501-5p expression was down-regulated in peripheral blood samples of septic patients with cardiac dysfunction, lipopolysaccharide (LPS)-induced cardiomyocytes, and the myocardium and peripheral blood in the septic model. Moreover, it was revealed that miR-501-5p overexpression could increase left ventricular diastolic pressure (LVDP), fractional shortening (FS), ejection fraction (EF), and maximum rate of the rise of left ventricular pressure (+dp/dt) in vivo, while it decreased the levels of myocardial injury-related indicators. In addition, LPS induction accelerated apoptosis and elevated the inflammation in HL-1 and HCM cells, which could be reversed by miR-501-5p overexpression. Mechanistically, we considered nuclear receptor subfamily 4 group A member 3 (NR4A3) as the target of miR-501-5p, and it was found that miR-501-5p prevented the binding between NR4A3 and Bcl-2. It was found that miR-501-5p exerted an inhibitory effect on cardiomyocyte apoptosis and inflammation in a NR4A3-dependent manner. Overall, our results may provide evidence for consideration of miR-501-5p in the therapy of sepsis.

Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study
Litao Guo, Yandong Hu, Qinjing Zeng et al.|Therapeutic Apheresis and Dialysis|2023
Cited by 3Open Access

INTRODUCTION: This study aimed to analyze the factors affecting continuous renal replacement therapy (CRRT) duration in critically ill patients and provide a reference for clinical treatment. MATERIAL AND METHODS: We divided patients into regional citrate anti-coagulation (RCA) and low-molecular-weight-heparin (LMWH) groups according to the anti-coagulation method and collected the relevant data, to analyze the factors associated with CRRT time. RESULTS: Compared with the LMWH group, the RCA group had a longer mean treatment time (55.36 ± 22.57 vs. 37.65 ± 27.09 h, p < 0.001), lower transmembrane pressure, and lower filter pressure, regardless of vascular access site. Multivariable linear regression analysis showed a significant correlation between anti-coagulation patterns, filter pressure at CRRT discontinuation, nurses' level of intensive care unit experience, pre-machine fibrinogen level, and CRRT time. CONCLUSION: Anti-coagulation is the most important factor affecting CRRT duration. Filter pressure, nurses' level of intensive care unit experience, and fibrinogen level also affecting CRRT duration.

Association of number of days with severe anemia in the first week with 28-Day mortality in patients with sepsis: propensity score-based analyses
Qinjing Zeng, Lei Zhang, Yongxing Wu et al.|Research Square|2024
Cited by 1Open Access

<title>Abstract</title> Anemia is a common occurrence during sepsis. However, the relationship between anemia duration and short-term effects on mortality in patients with sepsis remains unclear. This study examined the association between number of days with severe anemia in the first week and 28-day mortality rate among patients with sepsis. This retrospective cohort study used the clinical data extracted from Medical Information Mart for Intensive Care IV 2.2. A total of 1335 patients with sepsis were included in the study. After adjusting for confounders, the 28-day mortality of patients with sepsis increased with each additional day of severe anemia (hemoglobin level &lt; 8 g/dl) in the first week of intensive care unit admission with an odds ratio (OR) of 1.12 (95% confidence interval (CI) [1.05; 1.2], P &lt; 0.001). Furthermore, patients who experienced severe anemia for at least three days had a higher 28-day mortality rate than those with less severe anemia below three days (OR: 1.59, 95% CI [1.19; 2.11], P = 0.002). After employing various propensity score matching methods, we consistently observed a similar association. The adjusted ORs in propensity score matching, inverse probability of treatment weighting, standardized mortality ratio weighting, pairwise algorithmic, and overlap weight were 1.49 (95% CI, 1.08 ~ 2.07, P = 0.016), 1.65 (95% CI, 1.28 ~ 2.12, P &lt; 0.001), 1.49 (95% CI, 1.16 ~ 1.93, P = 0.002), 1.48 (95% CI, 1.07 ~ 2.04, P = 0.018), and 1.48 (95% CI, 1.01 ~ 2.17, P = 0.044) respectively. Thus, this study suggests that a longer duration of severe anemia in the first week may be linked to increased 28-day mortality in patients with sepsis.